4//SEC Filing
Smith Edward F 4
Accession 0001104659-21-034993
CIK 0001267813other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 4:04 PM ET
Size
8.5 KB
Accession
0001104659-21-034993
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2021-03-09$4.16/sh+35,927$149,456→ 53,644 total - Sale
Common Stock
2021-03-09$17.80/sh−40,356$718,337→ 13,288 total - Exercise/Conversion
Stock Option (right to buy)
2021-03-09−35,927→ 0 totalExercise: $4.16Exp: 2023-11-25→ Common Stock (35,927 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2020.
- [F2]The option was fully vested as of November 25, 2017.
Documents
Issuer
MARINUS PHARMACEUTICALS INC
CIK 0001267813
Entity typeother
Related Parties
1- filerCIK 0001368350
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 4:04 PM ET
- Size
- 8.5 KB